Sponsor
- Home
- Your Messages
-
Smartest Doc
Daily Quiz CompetitionTest your clinical knowledge against other physicians in the USA by taking our FREE daily quiz!
New! PHYSICIAN REVIEW
Thousands of questions to assess your knowledge and aid exam prep!
- More
- Other Specialty
E-cadherin as a predictive marker of brain metastasis in non-small-cell lung cancer, and its regulation by pioglitazone in a preclinical model
Journal of Neuro-Oncology, 05/14/2012
Yoo JY et al. – The authors found that E–cadherin expression was proportional to pioglitazone exposure time. Interestingly, pioglitazone pretreatment before cancer cell inoculation prevented loss of E–cadherin expression and reduced expression of MMP9 and fibronectin, compared with the control group. E–cadherin expression could be a predictor of brain metastasis in patients with non–small–cell lung cancer (NSCLC). Preventive treatment with pioglitazone may be useful for modulating E–cadherin expression.
Register now to view all the MDLinx contents (FREE)!
- Stay current on the latest literature, research and clinical news
- Get special communications and offers from MDLinx and our sponsors
- Receive invitations to paid market research
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Medical Student Jobs
@MDLinx Career Center
View the full listing of physician jobs
Sponsor